Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients-Reference-Cited by-同舟云学术

Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients

Published:2016-03-21 Issue:18 Volume:7 Page:25549-25557
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Deutsch Eric¹²³⁴,Haie-Meder Christine¹,Bayar Mohamed Amine⁵,Mondini Michele⁴,Laporte Mélanie⁶,Mazeron Renaud¹,Adam Julien⁶,Varga Andrea²,Vassal Gilles⁷,Magné Nicolas⁸,Chargari Cyrus¹⁴,Lanoy Emilie⁵⁹,Pautier Patricia²,Levy Antonin¹²⁴,Soria Jean-Charles²³

Affiliation:

1. Department of Radiation Oncology, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France

2. Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France

3. Paris-Sud University, Kremlin-Bicêtre Medical University, DHU TORINO, SIRIC SOCRATES, LABEX LERMIT, Le Kremlin-Bicêtre, France

4. I NSERM U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Villejuif, France

5. Biostatistics and Epidemiology Unit, Gustave Roussy Cancer Campus, Villejuif, France

6. Department of Medical Biology and Pathology, Translational Research Laboratory and Biobank (UMS3655 CNRS/US23 INSERM), INSERM Unit U981, Villejuif, France

7. Department of Clinical Research, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France

8. Department of Radiation Oncology, Institut de Cancérologie de la Loire-Lucien Neuwirth, Saint-Priest en Jarez, France

9. Inserm U1018 Centre for Research in Epidemiology and Population Health, Paris-Sud University, Villejuif, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entecavir: A Review and Considerations for Its Application in Oncology;Pharmaceuticals;2023-11-14

2. Reverse Translational Approach in Repurposing of Drugs for Anticancer Therapy;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023

3. The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics;Cells;2022-08-15

4. Combined modality including novel sensitizers in gynecological cancers;International Journal of Gynecologic Cancer;2022-03

5. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?;Cancers;2021-06-26